| 10.05.2012 15:30 |
DGAP-News: Biotest AG: Annual general meeting approves dividend |
| 10.05.2012 11:00 |
DGAP-News: Biotest AG: Biotest Group reports substantially higher EBIT |
| 08.05.2012 21:10 |
DGAP-Adhoc: Biotest AG: Preliminary investigation by public prosecution - Company rejects suspicions |
| 23.04.2012 12:19 |
DGAP-News: Biotest consolidates its outstanding position in the hepatitis B hyperimmunoglobulin market with the marketing authorisation of Fovepta and with the initial sales of Hepatect(R) in Brazil |
| 11.04.2012 16:33 |
DGAP-News: Biotest AG: Biotest announces clinical trial data for its new investigational Intravenous Immunoglobulin (IVIG) product for the US market |
| 22.03.2012 10:10 |
DGAP-News: Biotest AG: Biotest reached an all-time high Profit after Tax |
| 22.03.2012 10:00 |
DGAP-News: Biotest AG: BT-062 demonstrates rapid and complete tumor eradication in preclinical studies |
| 15.03.2012 14:43 |
DGAP-PVR: Biotest AG: Correction of the Publication according to § 26 paragraph. 1 WpHG from February 22, 2012 with the objective of Europe-wide distribution |
| 15.03.2012 14:37 |
DGAP-PVR: Biotest AG: Correction of a Publication according to § 26 paragraph. 1 WpHG from February 22, 2012 with the objective of Europe-wide distribution |
| 15.03.2012 14:29 |
DGAP-PVR: Biotest AG: Correction of a Publication according to § 26 paragraph. 1 WpHG from February 22, 2012 with the objective of Europe-wide distribution |
| 22.02.2012 15:53 |
DGAP-PVR: Biotest AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
| 22.02.2012 15:47 |
DGAP-PVR: Biotest AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
| 22.02.2012 15:37 |
DGAP-PVR: Biotest AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
| 20.02.2012 09:49 |
DGAP-Adhoc: Biotest AG: Slight increase in sales of 2.3% despite difficult market environment |
| 09.02.2012 09:18 |
DGAP-AFR: Biotest AG: Announcement according to Articles 37v, 37w, 37x et seqq. of the WpHG [the German Securities Act] with the objective of Europe-wide distribution |
| 12.12.2011 16:30 |
DGAP-News: Biotest AG: Clinical development of BT-062 in multiple myeloma expands into combination therapy |
| 24.11.2011 12:18 |
DGAP-News: Biotest AG: Tregalizumab (BT-061) shows efficacy in Chronic Plaque Psoriasis |
| 10.11.2011 10:00 |
DGAP-News: Biotest AG: Biotest: Significant Increase in Profit after Tax |
| 11.08.2011 09:00 |
DGAP-News: Biotest AG: First time Revenue and EBIT contribution by Biotherapeutics Segment; continuing difficult Plasma Protein Product Environment |
| 01.08.2011 17:19 |
DGAP-News: Biotest AG: Sale of Microbiological Monitoring business to Merck KGaA completed |
| 22.06.2011 16:07 |
DGAP-News: Biotest AG: Pentaglobin(R) shows high binding capacity against the current EHEC strain and its Shiga-like toxin 2 |
| 21.06.2011 15:03 |
DGAP-News: Biotest AG: Abbott and Biotest Announce Global Agreement to Development and Commercialize Novel Antibody for Autoimmune Diseases |
| 21.06.2011 14:59 |
DGAP-Adhoc: Biotest AG: Agreement with Abbott |
| 12.05.2011 17:19 |
DGAP-News: Biotest AG: Biotest AG: Annual General Meeting approves dividend increase |
| 10.05.2011 10:00 |
DGAP-News: Biotest AG: Sales increase in the first quarter |
| 28.04.2011 10:07 |
DGAP-Adhoc: Biotest AG: Ad hoc ANNOUNCEMENT |
| 22.03.2011 14:28 |
DGAP-News: Biotest AG: Biotest: Monoclonal antibody BT-061 in combination with methotrexate demonstrates good efficacy in Rheumatoid Arthritis |
| 22.03.2011 13:02 |
DGAP-News: Biotest AG: Sales increase despite difficult market environment |
| 22.03.2011 10:19 |
DGAP-Adhoc: Biotest AG: Ad-hoc RELEASE Announcement according to § 15 Sec. 1 Securities Trading Act (WpHG) |
| 25.02.2011 14:18 |
DGAP-AFR: Biotest AG: Announcement according to Articles 37v, 37w, 37x et seqq. of the WpHG [the German Securities Act] with the objective of Europe-wide distribution |
| 15.02.2011 09:00 |
DGAP-Adhoc: Biotest AG: Increase in sales of more than 5% |
| 27.01.2011 10:00 |
DGAP-News: Biotest AG: Interim analysis of the Cytotect(R) Phase III trial in congenital cytomegalovirus (CMV) infection shows clear indication of efficacy |
| 19.01.2011 17:11 |
DGAP-News: Biotest AG: Biotest erwirbt Vertriebsgesellschaft in Brasilien |
| 06.12.2010 01:00 |
DGAP-News: Biotest AG: Clinical and pre-clinical data emphasise the potential of |
| 17.11.2010 14:00 |
DGAP-News: Biotest AG: Biotest: Pre-clinical studies demonstrate high efficacy of BT-062 in solid tumours |
| 08.11.2010 10:00 |
DGAP-News: Biotest AG: Biotest experiences sales growth |
| 03.11.2010 16:59 |
DGAP-News: Biotest AG: Biotest submits BivigamTM dossier for regulatory approval to US Food and Drug Administration |
| 21.10.2010 10:26 |
DGAP-News: Biotest AG: Monoclonal antibody BT-061 shows potential in the indication multiple sclerosis |
| 12.08.2010 09:02 |
DGAP-News: Biotest AG: Positive perspective despite difficult environment |
| 11.08.2010 10:01 |
DGAP-News: Biotest AG: Development of BT-062 makes further progress with start of a new clinical trial |
| 10.08.2010 10:03 |
DGAP-News: Biotest AG: Immunomodulatory antibody BT-061 shows competitive efficacy in the indication Rheumatoid Arthritis |
| 10.08.2010 10:03 |
DGAP-News: Biotest AG: BT-061 patent protection significantly expanded |
| 14.07.2010 10:20 |
DGAP-News: Biotest AG: Biotest increases sales despite greater financial pressure |
| 14.07.2010 09:36 |
DGAP-Adhoc: Biotest AG: Preliminary Results |
| 11.05.2010 09:02 |
DGAP-News: Biotest AG: Biotest shows sales growth in first quarter 2010 despite a difficult environment |
| 06.05.2010 18:26 |
DGAP-News: Biotest AG: Annual General Meeting 2010: Shareholders Approve Dividend of EUR 0.34 per Ordinary Share and EUR 0.40 per Preference Share |
| 06.05.2010 12:04 |
DGAP-News: Biotest AG: Biotest has recorded sales growth in first quarter 2010 despite a difficult environment |
| 22.03.2010 15:21 |
DGAP-AFR: Biotest AG: Announcement according to Articles 37v, 37w, 37x et seqq. of the WpHG [the German Securities Act] with the objective of Europe-wide distribution |
| 19.03.2010 09:01 |
DGAP-News: Biotest AG: 2009 brings additional growth |
| 17.03.2010 12:01 |
DGAP-News: Biotest AG: Monoclonal antibody BT-061 shows efficacy in the indication psoriasis |
| 16.02.2010 08:52 |
DGAP-Adhoc: Biotest AG: Biotest significantly increases sales, EBIT above the high level of last year |
| 04.02.2010 11:31 |
DGAP-AFR: Biotest AG: Announcement according to Articles 37v, 37w, 37x et seqq. of the WpHG [the German Securities Act] with the objective of Europe-wide distribution |
| 06.01.2010 11:42 |
DGAP-News: Biotest AG: Sale of Medical Diagnostics business to Bio-Rad completed |
| 07.12.2009 09:14 |
DGAP-News: Biotest AG: Immunoconjugate BT-062 shows first data of clinical efficacy |
| 03.12.2009 18:26 |
DGAP-News: Biotest AG: European Commission grants approval of Zutectra(R) |
| 05.11.2009 09:04 |
DGAP-News: Biotest AG: Biotest increases sales and earnings |
| 23.10.2009 10:18 |
DGAP-News: Biotest agrees to sell its Medical Diagnostics business to Bio-Rad Biotest AG: |
| 23.10.2009 10:06 |
DGAP-Adhoc: Biotest AG: Biotest agrees to sell its Medical Diagnostics business to Bio-Rad |
| 20.10.2009 10:05 |
DGAP-News: Biotest AG: Monoclonal antibody BT-061 shows efficacy in patients with rheumatoid arthritis |
| 30.09.2009 11:19 |
DGAP-News: Biotest AG: Clinical development of BT-063 started |
| 28.09.2009 08:56 |
DGAP-News: Biotest AG: Biotest AG receives positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for approval of Zutectra across the EU |
| 12.08.2009 09:31 |
DGAP-News: Biotest AG:Biotest remains successful |
| 12.08.2009 09:09 |
DGAP-Adhoc: Biotest AG: Ad-hoc RELEASE; Announcement according to § 15 Sec. 1 Securities Trading Act (WpHG) |
| 07.07.2009 09:05 |
DGAP-News: Biotest AG: Further interim analyses confirm good clinical efficacy of the BT-061 monoclonal antibody. |
| 15.05.2009 14:32 |
DGAP-News: Biotest AG: Successful Start into 2009 |
| 07.05.2009 19:04 |
DGAP-News: Biotest AG: Annual General Meeting: Shareholders Approve Dividend of EUR 0,30 per Ordinary Share and EUR 0,36 per Preference Share |
| 07.05.2009 11:39 |
DGAP-Adhoc: Biotest AG: Press Release- Biotest AG: 'Biotest sales and EBIT growth in first quarter; extension of credit facility' |
| 07.04.2009 14:04 |
DGAP-News: Biotest AG: Expansion of product offering and capacity |
| 11.03.2009 10:38 |
DGAP-News: Biotest AG: Successful Financial Year 2008 |
| 11.02.2009 14:21 |
DGAP-News: Biotest AG: Biotest acquires further plasmapheresis centre |
| 04.02.2009 14:02 |
DGAP-Adhoc: Biotest AG: Biotest records significant growth in sales and earnings, |
| 03.02.2009 15:17 |
DGAP-AFR: Biotest AG: Announcement according to Articles 37v, 37w, 37x et seqq. of the WpHG [the German Securities Act] with the objective of Europe-wide distribution |
| 21.01.2009 09:37 |
DGAP-News: Biotest AG: Cooperation secures additional plasma protein capacity |
| 12.01.2009 09:17 |
DGAP-News: Biotest AG: Expansion of plasma protein product range |
| 15.12.2008 09:58 |
DGAP-News: Biotest AG: Enhanced property rights for BT-062 |
| 10.12.2008 10:09 |
DGAP-News: Biotest AG: Biotest expands plasma recovery capacities |
| 10.12.2008 09:57 |
DGAP-News: Biotest AG: European approval for Haemonine(R) |
| 28.10.2008 10:17 |
DGAP-Adhoc: Biotest AG: Majority shareholder of Biotest AG in discussions about selling shares |
| 17.10.2008 10:42 |
DGAP-News: Biotest AG: Biotest: proceeding successfully |
| 22.09.2008 10:39 |
DGAP-News: Biotest AG: Biotest: Promising start of clinical trial with BT062 |
| 08.09.2008 13:47 |
DGAP-News: Biotest AG: Biotest: monoclonal antibody BT-061 shows clear indications of efficacy in the treatment of Psoriasis |
| 18.08.2008 10:06 |
DGAP-News: Biotest AG: Biotest: US approval increases potential of diagnostic business |
| 07.08.2008 10:39 |
DGAP-News: Biotest AG: Biotest strengthens self-sufficiency in Plasma Proteins |
| 29.07.2008 09:49 |
DGAP-News: Biotest AG: Biotest awarded patent protection in the USA |
| 18.07.2008 11:35 |
DGAP-Adhoc: Biotest AG: strong first half year, profit target raised |
| 27.05.2008 14:28 |
DGAP-News: Biotest AG: Payout of dividends increased, forecast improved |
| 27.05.2008 11:35 |
DGAP-Adhoc: Biotest AG: Forecast for turnover and profit raised |
| 16.05.2008 16:22 |
DGAP-News: Biotest AG: Successful start into the Year 2008 |
| 05.05.2008 09:43 |
DGAP-News: Biotest AG: research into additional indications for monoclonal antibody BT-061 |
| 14.04.2008 09:34 |
DGAP-News: Biotest AG: European approvals expand the market potential for plasma proteins |
| 07.04.2008 15:43 |
DGAP-News: Biotest AG: Biotest: Successful launch of plasma protein business in the USA |
| 11.03.2008 09:12 |
DGAP-News: Biotest AG: Biotest achieves major milestones in the development of biotherapeutics |
| 22.02.2008 12:07 |
DGAP-News: Biotest AG: 2007 a very successful year for Biotest |
| 22.02.2008 11:11 |
DGAP-Adhoc: Biotest AG: Biotest marked increase in sales and earnings recorded in 2007 |
| 05.12.2007 14:59 |
DGAP-News: Biotest AG:Biotest successfully completes acquisition of Nabi Biologics assets |
| 09.11.2007 14:49 |
DGAP-News: Biotest AG: Nabi shareholders approve sale of Biologics Business Unit to Biotest |
| 05.11.2007 13:51 |
DGAP-News: Biotest AG: Biotest: plasmapheresis centre in Dortmund opens |
| 21.09.2007 09:39 |
DGAP-Adhoc: Biotest AG:Biotest successfully concludes 10% capital increase |
| 11.09.2007 08:44 |
DGAP-News: Biotest AG:Biotest AG acquires plasma protein business unit from Nabi Biopharmaceuticals Corp. |
| 11.09.2007 08:38 |
DGAP-Adhoc: Biotest AG:Biotest AG acquires plasma protein unit from Nabi Biopharmaceuticals Corp. |
| 10.08.2007 07:56 |
DGAP-News: Biotest AG: Biotest remains on course for growth |
| 01.08.2007 10:59 |
DGAP-News: Biotest AG:Biotest and Abbott cooperate on a clinical trial for the expansion of the indication of Cytotect(TM) |
| 19.07.2007 08:01 |
DGAP-Adhoc: Biotest AG: Biotest significantly increases sales and earnings target for 2007 |
| 16.07.2007 07:49 |
DGAP-News: Biotest AG: New clinical results increase market potential of Cytotect(TM) |
| 25.06.2007 12:28 |
DGAP-News: Biotest AG: Biotest achieves further milestones in its monoclonal antibody development |
| 15.06.2007 12:07 |
DGAP-News: Biotest receives go-ahead to export culture media to the USA |
| 03.05.2007 10:53 |
DGAP-News: Biotest AG: successful start to 2007 |
| 13.03.2007 16:23 |
DGAP-News: Biotest AG: Board of Management and Supervisory Board propose 82% dividend increase |
| 14.02.2007 10:19 |
DGAP-Adhoc: Biotest AG: Increase in sales and earnings in financial year 2006 higher than expected |
| 04.01.2007 22:35 |
DGAP-News: Biotest AG: Orphan drug status for Cytotect(TM) in the USA |
